₹ 1,990.50
-10.60 (-0.53%)
S
Sun Pharmaceutical
₹ 1,990.50
SUNPHARMA Fundamentals
Company Valuation
Market Cap (₹ Cr.)
4,77,588
PE Ratio
41.70
PB Ratio
5.74
Dividend Yield
0.80%
ROE
13.79%
ROCE
17.94%
Book Value (₹)
348.31
Face Value (₹)
1.00
Analyse SUNPHARMA with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Promoters | 54.48% | 54.48% | 54.48% | 54.48% | 54.48% |
| Domestic Institutional Investors (DII) | 19.50% | 20.24% | 20.82% | 21.11% | 22.18% |
| Foreign Institutional Investors (FII) | 17.26% | 16.55% | 16.12% | 15.93% | 14.53% |
| Public Investors | 5.35% | 5.53% | 5.40% | 5.30% | 5.48% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
SUNPHARMA Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Largecap
BSE Scrip Code
524715
NSE Scrip Name
SUNPHARMA
ISIN
INE044A01036



